Acsh.org3h
Rare Diseases Are Neglected. The FDA Needs A Dedicated 'Center of Excellence for Rare Diseases'.
The FDA has made some modest efforts, but it needs an internal organization that understands and would be an aggressive ...
The National Law Review22h
New HSR Rules Go Live: Your Playbook for Effective M&A
February 10, 2025, all merger filings will be subject to new Hart-Scott-Rodino (HSR) rules. The new HSR rules will ...
CNET15d
FDA Finally Bans Red Dye No. 3: What You Need to Know
Manufacturers that use Red No. 3 in food and ingested drugs must reformulate their products by Jan. 15, 2027, according to the FDA's new guidance. Imported foods that contain the dye will also ...
BBC15d
Drug use
The early morning operation targets multiple properties in Dover, Deal, Thanet and Aylesham. A report says the existing facility in Hartlepool's Whitby Street is in a deteriorating condition ...
NPR16d
The FDA pulls key DEI initiative for cancer studies from its website
The Food and Drug Administration has removed webpages about diversity and inclusion in clinical trials for cancer drugs. The page for Project Equity, a 2021 initiative launched by the FDA's ...
WHQR16d
The FDA pulls key DEI initiative for cancer studies from its website
Project Equity wasn't the first time the agency sought to address inclusivity problems in clinical trials, but it helped lead to the development of formal guidance around "diversity action plans." ...
OPB17d
The FDA pulls key DEI initiative for cancer studies from its website
Key guidance to industry on enhancing diversity in clinical trials of cancer drugs disappeared from the Food and Drug Administration website. The page for Project Equity, a 2021 initiative ...